AI Analysis AI Analysis of ACST
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Red day on Wednesday for Acasti Pharma stock after losing 0%
(Updated on Dec 04, 2024)

Buy or Hold candidate since Oct 09, 2024 Gain 1.81%

No changes to the price of Acasti Pharma stock on the last trading day (Wednesday, 4th Dec 2024). During the last trading day the stock fluctuated 0% from a day low at $3.37 to a day high of $3.37. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.17% during the next 3 months and, with a 90% probability hold a price between $4.07 and $5.42 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

ACST Signals & Forecast

The Acasti Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.37 and $3.37. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, October 25, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Acasti Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.12 and $3.07. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Acasti Pharma finds support just below today's level at $3.12. If this is broken, then the next support from accumulated volume will be at $3.07 and $3.06.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $3.17 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 27 days ago.)

Trading Expectations (ACST) For The Upcoming Trading Day Of Thursday 5th

For the upcoming trading day on Thursday, 5th we expect Acasti Pharma to open at $3.37, and during the day (based on 14 day Average True Range), to move between $3.34 and $3.40, which gives a possible trading interval of +/-$0.0283 (+/-0.84%) up or down from last closing price. If Acasti Pharma takes out the full calculated possible swing range there will be an estimated 1.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.40 (0.89%) than the support at $3.12 (7.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Acasti Pharma stock A Buy?

Acasti Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on December 5, 2024 - $3.37 ( 0.00000000%).

Trading levels for ACST

Fibonacci Support & Resistance Levels

Level Price
R3 3.37 0.00000000%
R2 3.37 0.00000000%
R1 3.37 0.00000000%
Price 3.37
S1 3.37 0.00000000%
S2 3.37 0.00000000%
S3 3.37 0.00000000%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.60 6.82%
R2 3.41 1.19%
R1 3.40 0.89%
Price 3.37
S1 3.12 -7.42%
S2 3.07 -8.90%
S3 3.06 -9.20%

FAQ

What is the symbol for Acasti Pharma Stock and on which exchange is it traded?
The symbol for Acasti Pharma is ACST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acasti Pharma Stock?
Acasti Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Acasti Pharma Stock?
Acasti Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acasti Pharma Stock.

What's the current price of Acasti Pharma Stock?
As of the end of day on the Dec 04, 2024, the price of an Acasti Pharma (ACST) share was $3.37.

What is the 52-week high and low for Acasti Pharma Stock?
The 52-week high for Acasti Pharma Stock is $3.60 and the 52-week low is $1.98.

What is the market capitalization of Acasti Pharma Stock?
As of the Dec 04, 2024, the market capitalization of Acasti Pharma is 34.171M.

When is the next earnings date for Acasti Pharma?
The upcoming earnings date for Acasti Pharma is Feb 10, 2025.
Click to get the best stock tips daily for free!
ABOUT ACASTI PHARMA
Acasti Pharma
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada....
GOLDEN STAR
Ticker Change Signal Date
OXLC
$5.25
0.95% Dec 02
G
GOF
$15.83
0.569% Dec 02
QSR
$69.61
2.13% Nov 29
HP
$34.63
1.27% Nov 29
B
BSCO
$21.11
0.118% Nov 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE